NEW YORK – Trovagene has begun enrolling patients into the Phase Ib/II trial of onvansertib evaluating the investigational PLK1 inhibitor as a treatment for KRAS-mutated metastatic colorectal cancer.
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?Register for Free.
This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries.